Clinuvel Pharmaceuticals Ltd (CLVLY)
10.00
+0.04
(+0.45%)
USD |
OTCM |
Sep 23, 16:00
Clinuvel Pharmaceuticals Total Assets (Quarterly): 154.48M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 154.48M |
| December 31, 2023 | 144.22M |
| June 30, 2023 | 128.22M |
| December 31, 2022 | 109.05M |
| June 30, 2022 | 99.02M |
| December 31, 2021 | 83.84M |
| June 30, 2021 | 81.57M |
| December 31, 2020 | 67.57M |
| June 30, 2020 | 56.03M |
| December 31, 2019 | 43.46M |
| June 30, 2019 | 43.66M |
| December 31, 2018 | 32.20M |
| June 30, 2018 | 31.52M |
| December 31, 2017 | 23.52M |
| June 30, 2017 | 21.98M |
| December 31, 2016 | 16.52M |
| June 30, 2016 | 15.04M |
| December 31, 2015 | 8.214M |
| June 30, 2015 | 10.46M |
| December 31, 2014 | 11.94M |
| June 30, 2014 | 16.15M |
| December 31, 2013 | 11.34M |
| June 30, 2013 | 14.67M |
| Date | Value |
|---|---|
| December 31, 2012 | 13.27M |
| June 30, 2012 | 16.05M |
| December 31, 2011 | 13.80M |
| June 30, 2011 | 21.55M |
| December 31, 2010 | 25.27M |
| June 30, 2010 | 24.82M |
| December 31, 2009 | 32.08M |
| June 30, 2009 | 33.54M |
| December 31, 2008 | 33.80M |
| June 30, 2008 | 52.64M |
| December 31, 2007 | 53.98M |
| June 30, 2007 | 57.50M |
| December 31, 2006 | 36.02M |
| June 30, 2006 | 12.67M |
| December 31, 2005 | 12.15M |
| June 30, 2005 | 7.661M |
| December 31, 2004 | 11.58M |
| June 30, 2004 | 7.140M |
| December 31, 2003 | 9.465M |
| June 30, 2003 | 5.428M |
| December 31, 2002 | 4.955M |
| June 30, 2002 | 5.923M |
| December 31, 2001 | 6.217M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
43.46M
Minimum
Dec 2019
154.48M
Maximum
Jun 2024
96.75M
Average
91.43M
Median
Total Assets (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 28.76M |
| Kazia Therapeutics Ltd | 16.61M |
| Immutep Ltd | 32.02M |
| Opthea Ltd | 166.50M |
| Mesoblast Ltd | 669.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.79M |
| Shareholders Equity (Quarterly) | 135.69M |
| Current Ratio | 8.808 |
| Net Debt Paydown Yield | 0.05% |